[PDF] Top 20 Cuerpos de mujeres, ciudadanía y violencia
Has 10000 "Cuerpos de mujeres, ciudadanía y violencia" found on our website. Below are the top 20 most common "Cuerpos de mujeres, ciudadanía y violencia".
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
... that tedizolid inhibited MPS more potently (50% inhibitory concentration [IC 50 ] ...high-dose tedizolid was ...at tedizolid doses that were approximately eightfold higher than those achieved in ... See full document
17
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
... current treatment options indicates a need to expand the available therapeutic ...arsenal. Tedizolid phosphate showed favorable results in the treatment ABSSSI in the first Phase III clinical ... See full document
59
Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections
... necrotizing infections, severe sepsis, known or suspected bacteremia, animal bites, aquatic exposures, infected burns, diabetic foot infection, immuno- suppression, and ...of treatment (EOT), and at a ... See full document
11
<p>Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy</p>
... Acute bacterial skin and skin-structure infections (ABSSSIs) are de fi ned as bacter- ial infections of the skin with a lesion area of at least 75 cm 2 ...mild ... See full document
5
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
... However, the longer duration of action may prove to be a safety concern, since any toxic effect or allergic reaction may continue for weeks until the agent has been cleared. The long half-life raises concerns as well ... See full document
13
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
... to acute bacterial skin and skin structure infections (ABSSSI) caused by resistant pathogens supports the need for new treatment ...the treatment of ABSSSI and ... See full document
16
Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting
... Acute bacterial skin and skin structure infections (ABSSSIs), which include cellulitis, abscesses, and wound infections, are among the most commonly encountered conditions ... See full document
72
Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
... Considering its expanded spectrum of activity against these resistant Gram-positive pathogens and its low potential for resistance, JNJ-Q2 shows promise as an effective treatment option for ... See full document
9
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.
... single-dose treatment of acute bacterial skin and skin structure infections ...the potential to shift the treatment of ABSSSI to the outpatient setting ... See full document
14
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
... Abstract: Acute bacterial skin and skin structure infections (ABSSSI) are a common disease causing patients to seek treatment through the health care ...drug-resistant ... See full document
41
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
... empiric treatment prior to microbial identification. Based on its activity profile, ceftobiprole has the potential to serve as a single agent for the empiric treatment of ... See full document
11
New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
... pharmacokinetic profile allowing for convenient dosing regimens and enhanced feasi- bility in the community or outpatient setting, and a minimal adverse effect ... See full document
9
New developments in the management of severe skin and deep skin structure infections – focus <br /> on tedizolid
... Abstract: Tedizolid, a novel oxazolidinone, is approved for treatment of acute bacterial skin and skin structure infections ...(ABSSSIs). Tedizolid offers ... See full document
12
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
... Abstract: Tedizolid phosphate has high activity against the Gram-positive microorganisms mainly involved in acute bacterial skin and skin structure infections, such ... See full document
5
Systematic review and network meta analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
... MRSA infections, it is opportune that we now have robust methods through NMA for comparing the relative efficacy of new and estab- lished agents by indirect ...before tedizolid was approved [36]; however, ... See full document
6
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection
... the tedizolid and linezolid arms (Table S4). Tedizolid and linezolid treatments resulted in similar absolute reductions in the mean lesion size at sequential time points (day 2, 48 to 72 h; day 7, and EOT ... See full document
37
Profile of bevacizumab and its potential in the treatment of cervical cancer
... factorial design trial, bevacizumab was given at the same dose as in the Phase II trial (15 mg/kg) with and without two separate chemotherapy doublets, either cisplatin plus paclitaxel or topotecan plus paclitaxel. ... See full document
11
Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer
... prior treatment, including other tyrosine kinase ...to treatment or placebo in a 2:1 ratio. Treatment continued until progression or unacceptable toxicity, and crossover and unblinding were not ... See full document
6
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
... the treatment of serious infections caused by Gram-positive bacteria, including complicated skin and skin structure infections (cSSSI) and ...combat infections caused by ... See full document
6
<p>Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials</p>
... S. aureus-, MRSA-, and MSSA-associated ABSSSIs. These fi ndings are supported by the results of in vitro investigations in an included study, 13 which showed that the minimum inhibitory concentration (MIC) of dela fl ox- ... See full document
87
Related subjects